Drug Approval | February 14, 2022
Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
It would be the first protein-based alternative available in Israel
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
Subscribe To Our Newsletter & Stay Updated
